NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Long Term Provisions History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Long Term Provisions | ₹2.70 Cr | ₹2.55 Cr | ₹2.46 Cr | ₹2.11 Cr | ₹1.40 Cr |
What is the latest Long Term Provisions ratio of NGL FINECHEM ?
Year | Long Term Provisions |
---|---|
Mar2023 | ₹2.70 Cr |
Mar2022 | ₹2.55 Cr |
Mar2021 | ₹2.46 Cr |
Mar2020 | ₹2.11 Cr |
Mar2019 | ₹1.40 Cr |
How is Long Term Provisions of NGL FINECHEM Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2023 | ₹2.70 Cr | 6.04 | |
Mar2022 | ₹2.55 Cr | 3.62 | |
Mar2021 | ₹2.46 Cr | 16.75 | |
Mar2020 | ₹2.11 Cr | 50.36 | |
Mar2019 | ₹1.40 Cr | - |
Compare Long Term Provisions of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,464.4 Cr | -6.8% | 10.6% | 76.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -6.8% |
10.6% |
76.3% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses